Adocia has reported positive results for the first clinical trial of its combination insulin formulation of fast- and long-acting insulin in patients with type I diabetes. Results showed that ...
PHOENIX--(BUSINESS WIRE)--PanTheryx, an integrative digestive and immune health company, today announced the expansion of its formulation capabilities to now include colostrum plus probiotic ...
Fixed-dose combination drug therapies give rise to innovation in solid-dosage formulations and manufacturing. As pharmaceutical companies face shortfalls in R&D productivity and increased generic-drug ...
NEW YORK, Aug. 29, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced its approval of a subcutaneous formulation of Leqembi (lecanemab), branded as Leqembi Iqlik, for ...
Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide. (Image Credits: Pixabay) Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a ...
Companies are leveraging combinations of drugs and other products to gain competitive advantage and market share. The development, commercialization, and utilization of drug combinations have ...
Metformin represents a biguanide that has been used globally for the treatment of diabetes mellitus type 2 during the last five decades. It improves glycemic control by enhancing insulin sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback